ganglioside sodium (GM3) 是免疫学中重要的一种分子,并可作为治疗神经退行性疾病的一种疗法。
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonic acid)-(2→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl-(1→1)-(2S,3R,4E)-2-amino-4-octadecene-1,3-diol | 94458-63-6 | C41H74N2O20 | 915.04 |
—— | (2S,3R,4E)-2-(N-tert-butyloxycarbonylamino)-3-hydroxoctadec-4-en-1-yl (5-N-acetyl-α-neuraminyl)-(2→3)-β-galactopyranosyl-(1→4)-β-glucopyranoside | —— | C46H82N2O22 | 1015.16 |
—— | (2S,3R,4E)-5'''-acetyl-α-neuraminyl-(2'''->3'')-β-galactopyranosyl-(1''->4')-β-glucopyranosyl-(1'<->1)-2-azido-4-octadecene-1,3-diol | 131057-14-2 | C41H72N4O20 | 941.037 |
4,7,8,9-四-O-乙酰基-N-乙酰神经氨酸甲酯 | 4,7,8,9-tetra-O-acetyl-N-acetylneuraminic acid methyl ester | 84380-10-9 | C20H29NO13 | 491.449 |
—— | lactosylceramide | 125712-73-4 | C48H91NO13 | 890.249 |
—— | N-[(2S)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1-(octylamino)-1-oxopropan-2-yl]-6-(prop-2-enoylamino)hexanamide | 196705-76-7 | C32H57N3O14 | 707.816 |
—— | cytidine-5'-monophosphono-N-acetylneuraminic acid | 3063-71-6 | C20H31N4O16P | 614.457 |
乳糖酰基鞘糖脂 | lactosyl sphingosine | 109785-20-8 | C30H57NO12 | 623.782 |
—— | (2S,3R,4E)-β-galactopyranosyl-(1''->4')-β-glucopyranosyl-(1'<->1)-2-azido-4-octadecene-1,3-diol | 109719-58-6 | C30H55N3O12 | 649.78 |
—— | (2R,3R,4R,5R,6R)-2-((E)-(2S,3R)-2-Azido-3-hydroxy-octadec-4-enyloxy)-4-triethylsilanyloxy-6-triethylsilanyloxymethyl-5-((2S,3R,4S,5S,6R)-3,4,5-tris-triethylsilanyloxy-6-triethylsilanyloxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-ol | 1054634-42-2 | C66H139N3O12Si6 | 1335.36 |